GM to take $6 billion charge after EV pullback — Negative

GM   Fast Company — January 09, 2026

General Motors will be hit with charges of about $6 billion as sales of electric vehicles sputter after the U.S. cut tax incentives to buy them and also eased auto emissions standards.

image for news GM to take $6 billion charge after EV pullback

Macy's plans to close 14 underperforming stores this year, after shuttering 66 in 2025 and 55 the year before. Following the next round of closures—most expected in the first quarter—the company will be 80% of the way toward its goal of 150 closings that was outlined in the “Bold New Chapter” turnaround plan presented by CEO Tony Spring in February 2024.

image for news Macy's To Close Only 14 Stores As Its ‘Bold New Chapter' Plan Bears Fruit

The AI Supercycle: Navigating Concentration Risk in 2026 — Positive

AIQ  IGPT  IXN  WTAI   ETF Trends — January 09, 2026

As the 2026 market landscape takes shape, artificial intelligence (AI) continues to serve as the primary catalyst for global equity performance. According to BlackRock's 2026 outlook, AI remains the “dominant theme” for the investment community, fueling a capital-intensive expansion that is fundamentally supporting corporate earnings and broader macroeconomic growth.

image for news The AI Supercycle: Navigating Concentration Risk in 2026

SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) saw the price of their shares crater 50% on December 31, 2025 after the company announced its receipt of a complete response letter (“CRL”) from the FDA for its proposed treatment of patients with hypercortisolism (also known as Cushing's syndrome) – relacorilant.

image for news Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (the “Company”) (NYSE: MCB), the holding company for Metropolitan Commercial Bank, today announced it will release fourth quarter and full year 2025 financial results after the market closes on Tuesday, January 20, 2026. The Company will conduct a conference call at 9:00 a.m. ET on Wednesday, January 21, 2026, to discuss the results. To access the event by telephone, please dial 800-245-3047 (US), 203-518-9765 (INTL), and provide confer.

image for news Metropolitan Bank Holding Corp. Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Dates

$75,000 in State Strategic Impact grants awarded in 2025 DAVENPORT, Iowa, Jan. 9, 2026 /PRNewswire/ -- The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., and Iowa American Water, announced today that the Foundation awarded a combined total of $75,000 in State Strategic Impact grants to 13 organizations in Iowa service areas. "The American Water Charitable Foundation's support has made a truly meaningful difference for families experiencing hunger across our region," said Dorie Arp-Benore, Director of Donor Relations, River Bend Food Bank.

image for news Iowa American Water Proudly Recognizes American Water Charitable Foundation State Strategic Impact Grant Recipients

Amazon: The World's No. 1 Hyperscaler Is Definitely Not 'AI Hype' — Neutral

AMZN   Seeking Alpha — January 09, 2026

Amazon: The World's No. 1 Hyperscaler Is Definitely Not 'AI Hype'

image for news Amazon: The World's No. 1 Hyperscaler Is Definitely Not 'AI Hype'

Global Mofy AI Limited (GMM) Q4 2025 Earnings Call Transcript — Neutral

GMM   Seeking Alpha — January 09, 2026

Global Mofy AI Limited (GMM) Q4 2025 Earnings Call Transcript

image for news Global Mofy AI Limited (GMM) Q4 2025 Earnings Call Transcript

Hims & Hers Health: Capitalizing On Healthcare Innovation — Negative

HIMS   Seeking Alpha — January 09, 2026

Hims & Hers Health remains a speculative buy for aggressive growth investors, driven by its pivot toward precision medicine and AI-enabled healthcare. Recent volatility stems from regulatory risks, the Novo Nordisk partnership breakup, and shifting GLP-1 compounding regulations impacting revenue and investor sentiment. HIMS's valuation sits between telehealth and AI/genomics peers, with substantial upside if it becomes more like AI/genomics companies but significant downside if risks materialize.

image for news Hims & Hers Health: Capitalizing On Healthcare Innovation

Middlesex Water Company has typically held less appeal than some undervalued peers in the sector - that may be about to change following the recent results. I look at the company as an investment potential for the year of 2026. Learn why I believe that MSEX is now a potentially better investment than other companies in the field, and if there are companies that I view as better-suited.

image for news Middlesex Water Company: Others Were More Attractive, But This Is Getting There

3 Industrial Names That Will Benefit from Rising CapEx in 2026 — Positive

EMR  FLR  JCI   MarketBeat — January 09, 2026

Industrial stocks were one of the best-performing asset classes in 2025. The Vanguard Industrials ETF NYSEARCA: VIS, a fund that tracks the broader sector, was up over 21% for the year, outpacing the S&P 500 Index, which returned around 16%.

image for news 3 Industrial Names That Will Benefit from Rising CapEx in 2026

LCNB Corp.: A Rare Mix Of Quality And Price — Positive

LCNB   Seeking Alpha — January 09, 2026

LCNB Corp. earns a soft "Buy" rating, supported by high asset quality and attractive valuation metrics. LCNB demonstrates balance sheet growth, diversified loan exposure, and resilient non-interest income despite sector volatility. Net interest margin volatility has pressured earnings, but recent margin recovery and improved credit quality are encouraging.

image for news LCNB Corp.: A Rare Mix Of Quality And Price

Gold breaks $4,500 as a cooling labor market strengthens bull case — Positive

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Kitco — January 09, 2026

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

image for news Gold breaks $4,500 as a cooling labor market strengthens bull case

Gibbens: AMZN Rebound Incoming, PNC Top Pick & SNOW's Software Edge — Positive

AMZN  PNC   Schwab Network — January 09, 2026

Mark Gibbens is feeling very bullish for 2026 due to economic and FOMC tailwinds. He remains constructive on the Mag 7 and expects Amazon (AMZN) to experience a stark rebound following 2025's lagging performance.

image for news Gibbens: AMZN Rebound Incoming, PNC Top Pick & SNOW's Software Edge

Sets Date to Report Preliminary Fourth Quarter 2025 Financial Results Sets Date to Report Preliminary Fourth Quarter 2025 Financial Results

image for news Proficient Auto Logistics Announces Participation in Stifel Transportation & Logistics Conference

Revolution is developing drugs that target a molecular driver of cancers.

image for news Merck is in talks to acquire Revolution Medicines in a deal that could value the cancer-drug biotech at around $30 billion

Why History Says We Could See the Nasdaq Double — Positive

FOMO  SHOP   Zacks Investment Research — January 09, 2026

Stocks have staged a remarkable rally since the Liberation Day lows, and Andrew Rocco believes the bull market still has plenty of room to run. Discover how the 1999 internet boom can help you capitalize on this powerful trend in 2026 and beyond.

image for news Why History Says We Could See the Nasdaq Double

NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

image for news ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit

TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase and sale of an aggregate of 66,666,666 Class A ordinary shares of the company, no par value per share (the “Shares”) (or pre-funded warrants in lieu thereof), at a purchase price of $0.15 per share in a registered direct offering. The purchase price for each pre-funded warrant is identical to the purchase price for each Share, less the exercise price of $0.001 per share.

image for news China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering

SAN FRANCISCO, Jan. 9, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) following the company's Q3 2025 financial disclosures that revealed significant adverse accounting adjustments totaling about $90 million and sent the stock tumbling over 33% in mid-November. The lawsuit seeks to represent investors who purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025.

image for news Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge - Hagens Berman